Antigua and Barbuda vs Niue: Share of one-year-olds vaccinated against Haemophilus influenzae type B
Antigua and Barbuda
99.0%
in 2024
Niue
99.0%
in 2024
Antigua and Barbuda rank
1st
Niue rank
1st
Share of one-year-olds vaccinated against Haemophilus influenzae type B over time
- Antigua and Barbuda
- Niue
How they compare
Antigua and Barbuda currently reports 99.0% against 99.0% in Niue, a difference of 0.0%.
The two have swapped places 2 times across 24 shared years of data; in 2001 it was Niue ahead.
Antigua and Barbuda ranks 1st and Niue ranks 1st of 192 countries.
Niue has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Niue | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.3% | 98.6% | 1.2% | Niue |
| 2010s | 97.3% | 99.0% | 1.7% | Niue |
| 2020s | 97.4% | 99.0% | 1.6% | Niue |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of one-year-olds vaccinated against haemophilus influenzae type b, Antigua and Barbuda or Niue?
- Antigua and Barbuda, at 99.0% against 99.0% in Niue as of 2024.
- What is the difference in share of one-year-olds vaccinated against haemophilus influenzae type b between Antigua and Barbuda and Niue?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Niue?
- 24 years are reported by both, from 2001 to 2024.
- How do Antigua and Barbuda and Niue rank globally for share of one-year-olds vaccinated against haemophilus influenzae type b?
- Antigua and Barbuda ranks 1st and Niue ranks 1st of 192 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of one-year-olds vaccinated against Haemophilus influenzae type B. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had three doses of Haemophilus influenzae type b vaccine in a given year.